Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05370651 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05370651 · ClinicalTrials.gov record · last posted 2026-07-09

Emsella Chair vs Sham for Male Sexual Dysfunction

Study acronym: Emsella_EJD
StatusRecruiting
PhaseNot applicable
Started2022-12-14
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
We will be performing this study in 2 phases: Phase 1 will be an open label pilot study of 10 male participants. All participants in the pilot study will receive active treatment. If data from the pilot study is suggestive of symptom improvement, we will continue on to phase 2, which is a sham controlled, randomized blinded study. Participants in phase 2 will be randomized to receive either active treatment or sham. Potentially a total of 117 participants for both phases will be enrolled. The purpose of this study is to compare the Emsella Chair to sham and to determine whether electromagnetic technology is effective in the treatment of sexual dysfunction, specifically erectile dysfunction (EjD) in men.

Amendment record 12 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 12 times since 2022-05-06; most recent amendment 2026-07-07. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-10-28
Status change Not Yet Recruiting→Recruitingv3
Trial Details
NCT Number NCT05370651
Lead Sponsor Corewell Health East
Conditions Male Sexual Dysfunction, Ejaculatory Dysfunction
Enrollment 117 participants
Start Date 2022-12-14
Primary Completion 2028-07 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-09